rood blauwe elepsis logo Belegger.nl

Sopheon Terug naar discussie overzicht

sopheon weer online en.....

6 Posts
| Omlaag ↓
  1. sniper22 25 april 2006 15:20
    onderstaande info staat nu ook onder Financiel Releases vanwege het enterprise wide deployment verhaal!

    19 April 2006
    Electrolux Licenses Sopheon's Accolade Solution for Enterprise-Wide Deployment
    World's Leading Producer of Home Appliances Will Implement System to Enhance and Manage Innovation Processes

    --------------------------------------------------------------------------------

    Sopheon, an international software and services company, announced today that Electrolux, a global appliance manufacturer, has selected Sopheon's Accolade as its innovation process and product portfolio management solution.

    Electrolux will deploy the Sopheon system under an enterprise-wide agreement that covers company locations throughout Europe, the Americas, and the Asia-Pacific region, encompassing all product areas including Major, Floor Care and Small Appliances. Access will initially be provided to approximately 1400 users. Sopheon said that the licenses and services order is among the most financially substantial in its history. The contract described as imminent in Sopheon's results announcement issued yesterday has now been signed. Specific terms were not disclosed.

    Electrolux is the world's leading producer of home appliances for kitchen and cleaning use. Its products are sold in more than 150 countries under such well-known brands as AEG-Electrolux, Electrolux, Frigidaire and Eureka. Electrolux has stated publicly in recent months that product development is one of its core processes and that innovation is key to its ability to sustain its position of market leadership. Since year 2000 Electrolux has almost doubled its investments in product research and development.

    Electrolux's adoption of Accolade is part of a broad initiative by the company to change the way it develops new products. Electrolux will use Accolade's capabilities to help it more effectively prioritize investments in new product ideas and to guide its resource support for enhancements to existing products. The company expects Accolade to help strengthen the alignment between innovation strategies and day-to-day development activity, and to enable improved global collaboration among cross-functional teams responsible for conception and development of new products. Electrolux will also benefit from Accolade's capacity to integrate with Microsoft technology, allowing the company to extend the use and value of the Microsoft systems deployed throughout the company's worldwide operations.

    Sopheon partnered with Arthur D. Little, the global management consulting firm, in pursuing the Electrolux opportunity. Electrolux, Sopheon and Arthur D. Little will work together to implement the new system.

    "We measure innovation by the amount of business and shareholder value it generates," said Johan Hjertonsson, director of Electrolux's consumer innovation program. "Our goal is to continue to lead our industry in revenues and profits from innovation by supplying the market with a steady stream of premium, new-to-the-world products that consumers want. We chose Sopheon's solution because it will help us make the right front-end decisions on which product ideas to invest in, and enable us to increase the speed, efficiency and cost-effectiveness of the processes we use to move those product ideas from the drafting table to the marketplace. Accolade is the most complete tool we've found for supporting the business of innovation."

    "The Electrolux name is synonymous with innovation in the appliance industry," said Mike Connolly, European director for Sopheon. "And their strategies for maintaining their position of innovation leadership are clearly drawn. Accolade's capabilities are perfectly matched with Electrolux's requirements for increasing the visibility and coordination of its global product development efforts."
  2. Bertus S 25 april 2006 15:55
    quote:

    sniper22 schreef:

    onderstaande info staat nu ook onder Financiel Releases vanwege het enterprise wide deployment verhaal!

    Stond deze vorige week ook al hoor Sniper.

    Het merkwaardige is dat het 2 verschillende PB's zijn, 2e alinea laatste regel(s) zijn enigszins verschillend.

    Bertus S.
  3. Ibolyka-1 25 april 2006 16:10
    Aan Bertus.S

    Als nagenoeg de enige die bijna alles over Sopheon weet, hoeveel is momenteel een aandeel waard. Werkelijk dus geen koerswaarde!!
    Dit is nodig om eventueel in te stappen.
    Een paar maanden geleden heb ik zoiets van € 0,17 gelezen op dit forum.

    Bijvoorbaat mijn dank
  4. Ibolyka-1 25 april 2006 16:11
    Aan Bertus.S

    Als nagenoeg de enige die bijna alles over Sopheon weet, hoeveel is momenteel een aandeel waard. Werkelijk dus geen koerswaarde!!
    Dit is nodig om eventueel in te stappen.
    Een paar maanden geleden heb ik zoiets van € 0,17 gelezen op dit forum.

    Bijvoorbaat mijn dank
  5. Bertus S 25 april 2006 16:47
    Kan er vrij kort over zijn: Wat "de gek" er voor geeft!!!

    Geldt uiteraard voor vele fondsen, maar met de werkelijke waarde houd ik mij niet echt bezig........

    Denk dat vele fondsen dan zwaar overgewaardeerd zullen blijken te zijn, bijv. een Crucell, Antonov.

    Bertus S.

    P.S. vergelijk het het met een schilderij van een bekende schilder.

    Werkelijke waarde van een lap linnen, 15 potjes verf en 100 manuren zal met een €1000 goed betaald zijn.

    Verkoop/veilingprijzen zullen je wel kennen ter vergelijk.
6 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.016
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.617
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.618
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.747
Aedifica 3 912
Aegon 3.258 322.710
AFC Ajax 538 7.088
Affimed NV 2 6.296
ageas 5.844 109.891
Agfa-Gevaert 14 2.049
Ahold 3.538 74.333
Air France - KLM 1.025 35.034
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.775
Allfunds Group 4 1.470
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 243.015
AMG 971 133.257
AMS 3 73
Amsterdam Commodities 305 6.689
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.994
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.772
Arcelor Mittal 2.033 320.693
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.300
Aroundtown SA 1 219
Arrowhead Research 5 9.731
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.093
ASML 1.766 106.835
ASR Nederland 21 4.478
ATAI Life Sciences 1 7
Atenor Group 1 486
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.661
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392